These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 25536616)

  • 1. Enhanced cytotoxicity and apoptosis by thymoquinone in combination with zoledronic acid in hormone- and drug-resistant prostate cancer cell lines.
    Dirican A; Erten C; Atmaca H; Bozkurt E; Kucukzeybek Y; Varol U; Oktay Tarhan M; Karaca B; Uslu R
    J BUON; 2014; 19(4):1055-61. PubMed ID: 25536616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
    Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B
    BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zoledronic acid increases cytotoxicity by inducing apoptosis in hormone and docetaxel-resistant prostate cancer cell lines.
    Varol U; Degirmenci M; Karaca B; Atmaca H; Kisim A; Uzunoglu S; Sezgin C; Sanli UA; Uslu R
    Tumour Biol; 2015 Feb; 36(2):779-86. PubMed ID: 25293519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zoledronic acid effects interleukin-6 expression in hormone-independent prostate cancer cell lines.
    Asbagh LA; Uzunoglu S; Cal C
    Int Braz J Urol; 2008; 34(3):355-63; discussion 364. PubMed ID: 18601766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel combination of docetaxel and thymoquinone induces synergistic cytotoxicity and apoptosis in DU-145 human prostate cancer cells by modulating PI3K-AKT pathway.
    Dirican A; Atmaca H; Bozkurt E; Erten C; Karaca B; Uslu R
    Clin Transl Oncol; 2015 Feb; 17(2):145-51. PubMed ID: 25060568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of apoptosis-related molecules by synergistic combination of all-trans retinoic acid and zoledronic acid in hormone-refractory prostate cancer cell lines.
    Karabulut B; Karaca B; Atmaca H; Kisim A; Uzunoglu S; Sezgin C; Uslu R
    Mol Biol Rep; 2011 Jan; 38(1):249-59. PubMed ID: 20349282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting apoptosis in the hormone- and drug-resistant prostate cancer cell line, DU-145, by gossypol/zoledronic acid combination.
    Sanli UA; Gorumlu G; Erten C; Gul MK; Cengiz E; Kucukzeybek Y; Karaca B; Atmaca H; Uzunoglu S; Karabulut B; Uslu R
    Cell Biol Int; 2009 Nov; 33(11):1165-72. PubMed ID: 19716895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Docetaxel/zoledronic acid combination triggers apoptosis synergistically through downregulating antiapoptotic Bcl-2 protein level in hormone-refractory prostate cancer cells.
    Karabulut B; Erten C; Gul MK; Cengiz E; Karaca B; Kucukzeybek Y; Gorumlu G; Atmaca H; Uzunoglu S; Sanli UA; Baran Y; Uslu R
    Cell Biol Int; 2009 Feb; 33(2):239-46. PubMed ID: 19103299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on molecular mechanisms of growth inhibitory effects of thymoquinone against prostate cancer cells: role of reactive oxygen species.
    Koka PS; Mondal D; Schultz M; Abdel-Mageed AB; Agrawal KC
    Exp Biol Med (Maywood); 2010 Jun; 235(6):751-60. PubMed ID: 20511679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zoledronic acid influences growth, migration and invasive activity of prostate cancer cells in vitro.
    Mani J; Vallo S; Barth K; Makarević J; Juengel E; Bartsch G; Wiesner C; Haferkamp A; Blaheta RA
    Prostate Cancer Prostatic Dis; 2012 Sep; 15(3):250-5. PubMed ID: 22450844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic and anti-angiogenic effects of zoledronic acid in DU-145 and PC-3 prostate cancer cell lines.
    Gokalp C
    Mol Biol Rep; 2020 Oct; 47(10):7675-7683. PubMed ID: 32989500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in vitro anti-tumour activity of zoledronic acid and docetaxel at clinically achievable concentrations in prostate cancer.
    Morgan C; Lewis PD; Jones RM; Bertelli G; Thomas GA; Leonard RC
    Acta Oncol; 2007; 46(5):669-77. PubMed ID: 17562444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptotic activities of thymoquinone, an active ingredient of black seed (Nigella sativa), in cervical cancer cell lines.
    Ichwan SJ; Al-Ani IM; Bilal HG; Suriyah WH; Taher M; Ikeda MA
    Chin J Physiol; 2014 Oct; 57(5):249-55. PubMed ID: 25241984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination of zoledronic acid and serine/threonine phosphatase inhibitors induces synergistic cytotoxicity and apoptosis in human breast cancer cells via inhibition of PI3K/Akt pathway.
    Surmeli Z; Gursoy P; Erdogan AP; Bozkurt E; Atmaca H; Uzunoglu S; Sezgin C; Şanlı UA; Uslu R; Karaca B
    Tumour Biol; 2016 Mar; 37(3):3665-73. PubMed ID: 26462835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic suppression of human breast cancer cells by combination of plumbagin and zoledronic acid In vitro.
    Qiao H; Wang TY; Yan W; Qin A; Fan QM; Han XG; Wang YG; Tang TT
    Acta Pharmacol Sin; 2015 Sep; 36(9):1085-98. PubMed ID: 26235741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-cancer properties and mechanisms of action of thymoquinone, the major active ingredient of Nigella sativa.
    Majdalawieh AF; Fayyad MW; Nasrallah GK
    Crit Rev Food Sci Nutr; 2017 Dec; 57(18):3911-3928. PubMed ID: 28140613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular Ca(2+)-dependent enhancement of cytocidal potency of zoledronic acid in human oral cancer cells.
    Inoue S; Arai N; Tomihara K; Takashina M; Hattori Y; Noguchi M
    Eur J Pharmacol; 2015 Aug; 761():44-54. PubMed ID: 25934567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymoquinone from Nigella sativa was more potent than cisplatin in eliminating of SiHa cells via apoptosis with down-regulation of Bcl-2 protein.
    Ng WK; Yazan LS; Ismail M
    Toxicol In Vitro; 2011 Oct; 25(7):1392-8. PubMed ID: 21609759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Additive/synergistic antitumoral effects on prostate cancer cells in vitro following treatment with a combination of docetaxel and zoledronic acid.
    Ullén A; Lennartsson L; Harmenberg U; Hjelm-Eriksson M; Kälkner KM; Lennernäs B; Nilsson S
    Acta Oncol; 2005; 44(6):644-50. PubMed ID: 16165924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zoledronic acid overcomes chemoresistance by sensitizing cancer stem cells to apoptosis.
    Rouhrazi H; Turgan N; Oktem G
    Biotech Histochem; 2018; 93(2):77-88. PubMed ID: 29300112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.